Receptor-destroying enzyme (RDE) from


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
26 04 2019
Historique:
received: 22 10 2018
revised: 20 02 2019
pubmed: 6 3 2019
medline: 8 1 2020
entrez: 6 3 2019
Statut: ppublish

Résumé

IgE plays a key role in allergies by binding to allergens and then sensitizing mast cells through the Fc receptor, resulting in the secretion of proinflammatory mediators. Therefore, IgE is a major target for managing allergies. Previous studies have reported that oligomannose on IgE can be a potential target to inhibit allergic responses. However, enzymes that can modulate IgE activity are not yet known. Here, we found that the commercial receptor-destroying enzyme (RDE) (II) from

Identifiants

pubmed: 30833330
pii: S0021-9258(20)36600-X
doi: 10.1074/jbc.RA118.006375
pmc: PMC6497938
doi:

Substances chimiques

Enzymes 0
Immunoglobulin G 0
Polysaccharides 0
Protease Inhibitors 0
Immunoglobulin E 37341-29-0
poly-N-acetyllactosamine 82441-98-3
Trypsin EC 3.4.21.4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6659-6669

Informations de copyright

© 2019 Yamazaki et al.

Références

J Gene Med. 2004 May;6(5):584-92
pubmed: 15133769
PLoS One. 2016 May 23;11(5):e0154264
pubmed: 27213644
Drug Metab Dispos. 2010 Feb;38(2):323-31
pubmed: 19923255
Glycobiology. 2007 Oct;17(10):1138-46
pubmed: 17693441
Cell Host Microbe. 2018 Feb 14;23(2):254-265.e7
pubmed: 29447697
Pharmacol Ther. 2018 Nov;191:50-64
pubmed: 29909239
Drug Des Devel Ther. 2009 Sep 21;3:7-16
pubmed: 19920917
Annu Rev Immunol. 2007;25:21-50
pubmed: 17029568
Virology. 1975 Dec;68(2):426-39
pubmed: 173078
Hum Antibodies. 2006;15(4):139-54
pubmed: 17522436
J Exp Med. 1998 Apr 20;187(8):1235-47
pubmed: 9547335
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2524-9
pubmed: 14983042
PLoS One. 2015 Aug 28;10(8):e0136394
pubmed: 26317642
J Biol Chem. 2011 Jun 10;286(23):20345-53
pubmed: 21471226
J Bacteriol. 2014 Nov;196(22):3937-48
pubmed: 25182499
Biochem Biophys Res Commun. 2008 Feb 8;366(2):445-9
pubmed: 18067856
Neurosci Res. 2006 May;55(1):45-53
pubmed: 16516319
J Exp Med. 1997 Feb 17;185(4):663-72
pubmed: 9034145
Nat Rev Immunol. 2004 Dec;4(12):978-88
pubmed: 15573132
Clin Proteomics. 2017 May 23;14:20
pubmed: 28546799
J Exp Med. 2015 Apr 6;212(4):457-67
pubmed: 25824821
J Allergy Clin Immunol. 2016 Jun;137(6):1646-1650
pubmed: 27090936
J Allergy Clin Immunol. 2001 Aug;108(2):184-90
pubmed: 11496232
J Immunol. 2004 Apr 1;172(7):4486-92
pubmed: 15034065
J Gen Microbiol. 1961 Mar;24:409-25
pubmed: 13681288
Front Immunol. 2018 Jan 24;9:47
pubmed: 29416543
Gene Ther. 1999 Jul;6(7):1258-66
pubmed: 10455434
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12911-6
pubmed: 14569021
J Allergy Clin Immunol. 2016 Jun;137(6):1631-1645
pubmed: 27263999
Glycoconj J. 2016 Jun;33(3):447-56
pubmed: 26687240
J Immunol. 1952 Nov;69(5):563-74
pubmed: 13011314
PLoS One. 2014 Sep 22;9(9):e103119
pubmed: 25244128
J Immunol. 1967 Dec;99(6):1187-98
pubmed: 4168663
J Immunol. 1980 Jun;124(6):2728-37
pubmed: 7373045
Jpn J Infect Dis. 2011;64(1):40-9
pubmed: 21266754
J Biol Chem. 2002 Aug 16;277(33):29555-60
pubmed: 12042307
Histochem Cell Biol. 1996 Jun;105(6):459-65
pubmed: 8791105
Int Immunopharmacol. 2017 Feb;43:99-107
pubmed: 27988461
Methods Enzymol. 2010;478:181-95
pubmed: 20816480
Virology. 2004 Feb 5;319(1):107-17
pubmed: 14967492
J Biosci Bioeng. 2005 Dec;100(6):631-6
pubmed: 16473772
J Immunol. 1992 Aug 1;149(3):981-8
pubmed: 1634780
Nihon Ika Daigaku Zasshi. 1986 Oct;53(5):534-6
pubmed: 3536992
Mol Immunol. 1999 Feb;36(3):213-21
pubmed: 10403487

Auteurs

Tatsuya Yamazaki (T)

From the Department of Microbiology and Immunology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195.

Masanori Inui (M)

From the Department of Microbiology and Immunology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195.

Keiko Hiemori (K)

the Biotechnology Research Institute for Drug Discovery, National Institute of Advanced Industrial Science and Technology, 1-1-1 Umezono, Tsukuba, Ibaraki 305-8568.

Susumu Tomono (S)

From the Department of Microbiology and Immunology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195.

Makoto Itoh (M)

From the Department of Microbiology and Immunology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195.

Isao Ichimonji (I)

From the Department of Microbiology and Immunology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195.

Akina Nakashima (A)

From the Department of Microbiology and Immunology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195.

Hidekazu Takagi (H)

From the Department of Microbiology and Immunology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195.

Mrityunjoy Biswas (M)

From the Department of Microbiology and Immunology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195.

Kumi Izawa (K)

the Atopy Research Center, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421.
the Division of Cellular Therapy/Division of Stem Cell Signaling, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639.

Jiro Kitaura (J)

the Atopy Research Center, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421.
the Division of Cellular Therapy/Division of Stem Cell Signaling, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639.

Teruko Imai (T)

the Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-Honmachi, Kumamoto 862-0973, and.

Nobuo Sugiura (N)

From the Department of Microbiology and Immunology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195.

Hiroaki Tateno (H)

the Biotechnology Research Institute for Drug Discovery, National Institute of Advanced Industrial Science and Technology, 1-1-1 Umezono, Tsukuba, Ibaraki 305-8568.

Sachiko Akashi-Takamura (S)

From the Department of Microbiology and Immunology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195, sachiko@aichi-med-u.ac.jp.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH